The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer
verfasst von:
Adam Durczynski, Aleksander Skulimowski, Piotr Hogendorf, Dariusz Szymanski, Anna Kumor, Konrad Marski, Siri Øvereng Juliebø, Grazyna Poznanska, Janusz Strzelczyk
Several recent studies provide evidence that D-dimer (DD) concentration in peripheral blood correlates negatively with overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). Contrarily, there are recent evidence indicating that preoperative plasma fibrinogen, but not D-dimer might represent a prognostic factor in non-metastatic gastrointestinal cancers.
Methods
In a single-center prospective study, we enrolled 62 patients undergoing surgery for pathologically confirmed PDAC without detectable venous thrombosis. Intraoperatively, the sample of the blood from the portal vein was obtained. DD concentration in these samples was measured. Patients were followed postoperatively until time of death from any cause.
Results
We found that OS for patients with portal blood DD values above 2700 (ng/mL) (n = 22 from 62 patients) was higher by 158% than that for the patients (n = 42) with DD values ≤ 2700 (416 days versus 161 days, p = 0.05). On the contrary to the studies investigating DD concentration in peripheral blood, we have found that patients with higher DD level in the portal vein had longer mean OS than patients with lower ones.
Conclusions
Further investigation is necessary both to confirm our results in a larger patient population and to elucidate the mechanism for the correlation between portal blood D-dimer concentrations and survival time. Along with other authors, we conclude that portal circulation is characterized by unique, biological environment that requires further evaluation.
To the Editor:
Surgery remains the only potentially curative treatment for pancreatic ductal adenocarcinoma (PDAC); however, postoperative prognosis is variable and difficult to estimate. CA 19-9 has demonstrated clinical utility in this regard [1] but suffers from several limitations such as unclear cut-off points and inapplicability to Lewis antigen non-secretors. Therefore, there is a need to validate other prognostic biomarkers. Several recent studies provide evidence that D-dimer (DD) concentration in peripheral blood correlates negatively with overall survival (OS) in patients with PDAC [2, 3]. Contrarily, there is recent evidence indicating that preoperative plasma fibrinogen, but not D-dimer might represent a prognostic factor in non-metastatic gastrointestinal cancers [4]. In our previous research, we have extended investigations to DD concentration in bile, urine, and portal vein blood of patients with pancreatic cancer [5]. Following statistical analysis of our results, we have decided to investigate correlation between DD concentration in portal vein and overall survival (OS).
In a single-center prospective study, we enrolled 62 patients undergoing surgery for pathologically confirmed PDAC without detectable venous thrombosis. In all of them, during the surgery, tumor was found to be locally advanced and non resectable, but no metastatic lesions were identified. Such group of patients is characterized by lower predicted OS and extremely poor prognosis [3].
Anzeige
Intraoperatively, the sample of the blood from the portal vein was obtained. DD concentration in these samples was measured using VIDAS D-Dimer Exclusion II assay (bioMerieux, France). All of them were submitted to postoperative chemotherapy with gemcitabine. Patients were followed postoperatively until time of death from any cause. The study was approved by Ethics Committee of Medical University of Lodz in Poland. All statistical calculations were performed using SPSS version 20.0 for Windows (IBM Corporation, Armonk, NY).
We found that OS for patients with portal blood DD values above 2700 (ng/mL) (n = 22 from 62 patients) was higher by 158% than that for the patients (n = 42) with DD values ≤ 2700 (416 versus 161 days, p = 0.05) (Fig. 1). No statistically significant interaction was observed between the bile, urine and peripheral blood DD levels and OS of these patients.
Fig. 1
Correlation of portal blood D-dimers with overall survival of patients with nonresectable pancreatic cancer. Kaplan-Meier curve
×
On the contrary to the studies investigating DD concentration in peripheral blood, we have found that patients with higher DD level in the portal vein had longer mean OS than patients with lower ones. The shorter OS has been reported in PDAC as well as in the other cancers with higher DD concentration in the peripheral blood. Fukumoto et al. found that elevated DD concentration in peripheral blood predicts shorter OS in resected non-small cell lung cancer independently of age, gender, stage of the tumor, and level of circulating carcinonembryonic antigen [6]. Ay et al. likewise find elevated DD to predict poor prognosis in all studied solid organ tumors [7]. This clearly shows that D-Dimer levels in the portal and peripheral blood cannot be treated as equivalent.
In pancreatic cancer, not extending the barrier of retroperitoneal space or metastasizing to the liver, all venous blood from the tumor has to be drained to the portal circulation. Therefore, in such cases, portal blood D-dimer concentration reflects fibrinolysis at the site of the primary pancreatic cancer.
Anzeige
As we have previously demonstrated in many cases of pancreatic cancer that did not cross the retroperitoneal barrier and did not metastasize to liver, the D-dimer levels in the portal vein are several times greater than those in the peripheral blood. This cannot be explained only by the phenomenon of dilution of portal blood in the general circulation, because only about 20% of the total volume of circulating blood passes through the portal system.
We hypothesized and confirmed that liver acts as a filter for portal DD by excreting them into bile. The concentration of D-dimers in the peripheral blood is significantly increased when the pancreatic cancer breaks the liver barrier or the tumor begins to infiltrate the retroperitoneal space, hence, the high D-dimer levels in both portal and peripheral blood in patients with metastatic pancreatic tumor. The latter reflect mostly fibrinolysis of extra-gastrointestinal metastases and circulating tumor cells [8].
Directly, very high portal DD concentration may also confirm previously proposed hypothesis of fibrin scaffold surrounding pancreatic cancer from host’s immune system response [9]. On this basis, longer OS time in patients with higher intraoperative portal blood DD concentrations can be explained.
Our study adds to the growing body of evidence that D-dimer concentrations have potential as prognostic biomarkers in pancreatic ductal adenocarcinoma. Further investigation is necessary to both confirm our results in a larger patient population and elucidate the mechanism for the correlation between portal blood D-dimer concentrations and survival time. Along with other authors [10], we conclude that portal circulation is characterized by unique, biological environment that requires further evaluation.
Acknowledgements
Not applicable.
Funding
Not applicable.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
The study was approved by the Local Ethics Committee of Medical University of Lodz, Poland. Written informed consent for the study was obtained from all participating patients.
Anzeige
Consent for publication
Written informed consent to publish was obtained from all participating patients.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer
verfasst von
Adam Durczynski Aleksander Skulimowski Piotr Hogendorf Dariusz Szymanski Anna Kumor Konrad Marski Siri Øvereng Juliebø Grazyna Poznanska Janusz Strzelczyk
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.
